ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ADIPOQ |
Q15848
|
adiponectin, C1Q and collagen domain containing
|
|
4.6E-09 |
0.376 |
0.885 |
ADRB2 |
P07550
|
adrenoceptor beta 2
|
G-protein coupled receptor
|
0.53 |
0.442 |
0.923 |
AICDA |
Q9GZX7
|
activation induced cytidine deaminase
|
Enzyme
|
9.2E-06 |
0.463 |
0.885 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
APEX1 |
P27695
|
apurinic/apyrimidinic endodeoxyribonuclease 1
|
|
1.9E-07 |
0.458 |
0.846 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
C4A |
P0C0L4 P0C0L5
|
complement C4A (Rodgers blood group)
|
Enzyme modulator
|
1.5E-11 |
0.563 |
0.769 |
CAMP |
P49913
|
cathelicidin antimicrobial peptide
|
|
4.4E-03 |
0.466 |
0.846 |
CASP8 |
Q14790
|
caspase 8
|
Enzyme
|
3.7E-06 |
0.404 |
0.923 |
CASP9 |
P55211
|
caspase 9
|
Enzyme
|
7.4E-06 |
0.458 |
0.808 |
CCL20 |
P78556
|
C-C motif chemokine ligand 20
|
Signaling
|
2.4E-04 |
0.474 |
0.846 |
CCL3L1 |
P16619
|
C-C motif chemokine ligand 3 like 1
|
|
0.12 |
0.650 |
0.654 |
CCL5 |
P13501
|
C-C motif chemokine ligand 5
|
Signaling
|
1.8E-03 |
0.403 |
0.885 |
CCN1 |
O00622
|
cellular communication network factor 1
|
Signaling
|
0.71 |
0.473 |
0.731 |
CCR5 |
P51681
|
C-C motif chemokine receptor 5 (gene/pseudogene)
|
G-protein coupled receptor
|
4.3E-10 |
0.398 |
0.885 |
CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
CD80 |
P33681
|
CD80 molecule
|
|
1.1E-02 |
0.475 |
0.769 |
CD83 |
Q01151
|
CD83 molecule
|
|
5.2E-03 |
0.566 |
0.731 |
CD86 |
P42081
|
CD86 molecule
|
|
0.95 |
0.483 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |